#Global Stem Cell Banking Market Segmentation
Explore tagged Tumblr posts
kingsresearchinfo · 2 days ago
Text
Stem Cell Banking Market is Booming Worldwide 2024-2031
Stem Cell Banking Size was valued at USD 5,594.7 million in 2023 and is projected to grow from USD 15,349.0 million in 2023 to USD 15,349.0 million by 2031, exhibiting a CAGR of 13.58% during the forecast period. The market is experiencing robust expansion, mainly due to regulatory advancements that ensure safety and efficacy standards.
Tumblr media
Key Companies in Stem Cell Banking Market
CBR SyStem Cell Bankings, Inc. 
Cordlife India
Cryo-Cell International
ViaCord.
LifeCell International
Stem Cell BankingCyte India Therapeutics Pvt. Ltd
Global Cord Blood Corporation. 
Smart Cells International Limited
Vita 34
CryoHoldco
Browse Full Report Details @ https://www.kingsresearch.com/Stem Cell Banking-cell-banking-market-942
Regional Analysis:
The market has been divided by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Stem Cell Banking market in the Americas has further been divided into North America and Latin America, with the North American market divided into the US and Canada.
The existence of key market participants and sophisticated healthcare infrastructure, expanding network of Stem Cell Banking services, and continuous efforts by researchers to explore new therapeutic applications of cord blood cells in the US and Canada is assisting in the dominance of North America. The European Stem Cell Banking market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Stem Cell Banking market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is likely to register the fastest market growth over the forecast period owing to surging elder population, increasing product launches, growing investments in R&D projects, and the presence of favorable regulatory policies coupled with commercialization opportunities. The Stem Cell Banking market in the Middle East & Africa has been divided into the Middle East and Africa.
Stem Cell Banking Market: 
By Service Types:
Collection & Transportation
Processing
Analysis
Storage
By Utilization:
Used
Unused
By Cell Type:
Umbilical Cord Stem Cell Banking Cell
Adult Stem Cell Banking Cell
Embryonic Stem Cell Banking Cell
For instance, in August 2018, the Ministry of Science and Technology (MOST) of the Government of China published a draft of the “2019 Annual Project Application Guide” for the Stem Cell Banking Cell and Transformation Research pilot project. The government proposed investing 400 million yuan (around USD 56.4 million) to support Stem Cell Banking cell research in China. On the other hand, high operational and storage costs and dearth of awareness about Stem Cell Banking in developing and underdeveloped nations are anticipated to impede the market growth during the forecast period.
Future Outlook:
The future of the Stem Cell Banking market looks promising, with continued growth expected over the coming years. The market's expansion will be driven by ongoing research, technological advancements, and the increasing adoption of Stem Cell Banking cell therapies. Emerging markets in Asia Pacific and Latin America offer significant opportunities for growth, as awareness and healthcare infrastructure improve.
About Us:
At the core of our mission, we strive to drive revenue impact for our clients through exceptional research strategies. With a focus on exclusivity, innovation, and real-time insights, we provide accurate, reliable, and actionable market research data. This empowers our clients to seize opportunities, navigate risks, optimize their strategies effectively, and build the businesses of tomorrow.
0 notes
market-insider · 4 days ago
Text
Exploring the Cell Harvesting System Market: Detailed Insights on Size, Share, Growth Potential
The global cell harvesting system market size is expected to reach USD 13.22 billion by 2030, registering a CAGR of 14.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for stem cell-based therapies, owing to the growing base of aging population and increasing prevalence of chronic diseases, is one of the major factors contributing toward lucrative market growth.
Tumblr media
Cell Harvesting System Market Report Highlights
The peripheral blood segment dominated the market in terms of revenue share of 31.4% in 2023 pertaining to the widespread use of peripheral blood stem cell (PBSC) harvesting driven by its slightly invasive nature and the increasing demand for stem cell treatments.
In 2023, hospitals dominated the cell harvesting market mainly for spending on storage units and cryogenic preservation techniques. Besides, the research and development conducted by hospitals is also a significant factor for the segment growth.
North America cell harvesting system market accounted for a market share of 39.4% in 2023. The presence of a highly developed medical and healthcare infrastructure fuels a significant share of the cell harvesting market over the forecast period.
For More Details or Sample Copy please visit link @: Cell Harvesting System Market Report
Growing investment in stem cell research is one of the high impact rendering drivers contributing to the demand for stem cells, which thereby contributes to the growth of the cell harvesting system market. There has been a significant rise in the stem cell transplantation rate globally, which is another major driver for increasing demand across the globe. Growth in autologous stem cell transplantation along with increasing stem cell banking is stimulating demand for cell harvesting system.
The potential use of stem cells in regenerative medicine, such as in the case of cancer, trauma, congenital diseases, etc., is also one of the factors contributing to the demand for stem cells for research, thereby contributing toward the growth of cell harvesting system market across the globe. The rising prevalence of certain diseases such as cancer is expected to drive the growth of this market over the forecast period.
List of major companies in the Cell Harvesting System Market
Argos Technologies, Inc.
Perkin Elmer, Inc.
Brand GmBh+ CO KG
Arthrex, Inc.
Avita Medical
Tomtec
Terumo Corporation
Teleflex, Inc.
Bertin
Sartorius AG
For Customized reports or Special Pricing please visit @: Cell Harvesting System Market Analysis Report
We have segmented the global cell harvesting system market on the basis of on type, application, end-use, and region.
0 notes
latestmarketresearchnews · 12 days ago
Text
Biopreservation Industry Research Report 2030 by Key Growth Drivers, Leading Players Review
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold 
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
researchreportinsight · 12 days ago
Text
Biopreservation Industry 2030 Trends, Growth, Revenue, Outlook and Future Estimation
The global biopreservation market, valued at USD 2.18 billion in 2022, is poised for significant growth, with an anticipated compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. Biopreservation techniques are widely adopted in hospitals, laboratories, and research institutions for preserving biological specimens such as stem cells, tissues, DNA, and organs. These techniques ensure the longevity and functionality of samples, enabling advancements in medical research and treatment. The market benefits from substantial funding by government bodies and private organizations. These funds facilitate research and development (R&D) activities and drive advancements in biopreservation technologies.
The growing focus on life sciences research and clinical studies has led to innovations in preservation technologies. Companies like BioLife Solutions are expanding their portfolios. In April 2021, BioLife launched a high-capacity controlled freezer tailored for the cell and gene therapy market, addressing the growing demand in this segment. Innovative solutions are reducing the complexity and costs associated with biopreservation. The introduction of multiplex cellular imaging platforms enables better analysis of disease progression, paving the way for tailored diagnostics and treatments in areas like cardiology, gynecology, and point-of-care applications.
The global biopreservation market is on a robust growth trajectory, fueled by advancements in technology, increased funding, and rising demand for biologics and biospecimens. While North America leads the market due to its advanced infrastructure and strong research ecosystem, Asia Pacific is emerging as a dynamic region with rapid adoption of biopreservation techniques. Strategic initiatives by key players and government support are expected to further drive the market’s expansion, positioning biopreservation as a critical component in the future of healthcare and life sciences.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Regional Insights:
North America Biopreservation Market Trends
North America accounted for 45.00% of global revenue in 2022, driven by advanced biomedical research and innovative therapies.
Key Growth Factors:
High prevalence of chronic diseases requiring biopreservation for treatment.
Strong support from organizations like the National Institutes of Health (NIH) and National Cancer Institute (NCI).
Biobanks in the U.S. play a pivotal role in supporting research and clinical trials, further boosting demand for biopreservation technologies.
Asia Pacific Biopreservation Market Trends
Asia Pacific is projected to grow at a CAGR of 30.47% over the forecast period.
Key Drivers:
Rising funding for bio-banking techniques.
Increasing collaborations and partnerships to develop advanced biopreservation services.
Governments in this region are actively investing in R&D and promoting public-private partnerships to bolster the adoption of biopreservation.
Browse through Grand View Research's Category Biotechnology Industry Research Reports.
The global automated and closed cell therapy processing systems market size was valued at USD 1.41 billion in 2024 and is projected to grow at a CAGR of 19.8% from 2025 to 2030.
The global cell culture media storage containers market size was estimated at USD 2.11 billion in 2024 and is projected to witness a CAGR of 12.55% from 2025 to 2030.
Key Companies & Market Share Insights:
The biopreservation market is highly competitive, with major players focusing on strategic initiatives to maintain their market positions. Common strategies include:
Geographical Expansion: Companies are entering untapped markets to capitalize on growth opportunities.
Partnerships and Collaborations: Key players are joining forces with research institutions and governments to expand their services.
In January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service. This initiative provides researchers with access to high-quality tissue samples, highlighting the growing importance of biobanks in advancing medical research.
Key Biopreservation Companies:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
Stirling Ultracold 
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
marketanalysisdata · 23 days ago
Text
Biopreservation Market Revenue, Share and Growth Rate to 2030
The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.
Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.
In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.
However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.
Application Segmentation Insights:
In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.
The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
marketstudyreport · 23 days ago
Text
Biopreservation Market Competitive Landscape and Industry Analysis 2030
The global biopreservation market was valued at USD 2.18 billion in 2022, and it is expected to grow at an impressive compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. This growth is driven by various factors, including extensive applications in healthcare settings like hospitals and laboratories, increased funding from both government and private entities, and advancements in research and development, particularly in the development of new products. For instance, BioLife Solutions introduced a new high-capacity controlled freezer in April 2021, aimed at supporting the cell and gene therapy sector. This addition helped the company expand its product range within biopreservation. The COVID-19 pandemic initially posed challenges for the industry, with disruptions in supply chains, shortages of raw materials, and slowdowns in research activities. However, it also accelerated interest and investment in biologics and vaccine technologies, which ultimately increased the demand for biopreservation solutions, especially for biologics manufacturing and preservation.
Biopreservation is a technique that enables the maintenance of biological materials such as stem cells, DNA, tissues, and organs under controlled temperatures, extending their viability outside their natural environment. Advances in technology, including microarrays, hybrid predictive models, and various API algorithms, are helping to streamline the biopreservation process by reducing its time, cost, and complexity. Additionally, the development of multiplex cellular imaging platforms is expected to boost biopreservation capabilities, especially in supporting disease research. These imaging platforms allow for better analysis of disease progression and facilitate targeted diagnostic and treatment strategies, benefiting fields like cardiology, gynecology, and point-of-care medicine.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Demand for biopreservation has significantly increased in the research and development of biologics across various sectors, including immunotherapy, vaccine production, antibody development, enzyme technology, and bio-manufacturing of chemicals. This surge is partially due to the rising global prevalence of chronic diseases. For example, according to the Centers for Disease Control and Prevention (CDC), cardiovascular diseases and cancer remain among the leading causes of mortality in adults in the United States.
In addition, government and private investments in research and development have spurred significant advancements in the market. There is growing demand for preserving stem cells and creating new biological treatments and products, which has attracted considerable attention and funding from investors. The substantial healthcare spending in this sector is likely to fuel the market's growth in the coming years.
However, the expanding biopreservation market faces some challenges. Key issues include a shortage of skilled professionals, high costs for training, and limited standardization in cybersecurity measures for biopreservation software. These factors may pose risks to market growth by adding complexity and increasing costs for companies operating in this space.
Application Segmentation Insights:
In terms of applications, the biobanking segment held a significant portion of the global market, accounting for 70.65% in 2022. The increasing awareness of stem cell preservation, rising acceptance of sperm and egg banking, and the use of assisted reproductive technologies in animals have all contributed to the segment’s growth. Many pharmaceutical companies are now collaborating with biobanks and hospitals for tissue and biological sample preservation.
The regenerative medicine segment is expected to grow at a higher CAGR of 29.68% during the forecast period, driven by a strong demand for advanced bio-storage techniques. Innovations in specific preservation techniques are likely to further boost growth in this segment over the coming years.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
harshnews · 1 month ago
Text
Thawing Equipment Market Size, Share, Trends, Growth Opportunities and Competitive Outlook
"Global Thawing Equipment Market – Industry Trends and Forecast to 2029
Global Thawing Equipment Market, By Product (Manual, Automatic), Sample (Blood Products, Ovum/Embryo, Semen, Human Tissue Samples, Organs, Stem Cells, Other), End User (Blood Banks and Transfusion Centers, Hospitals, Research Laboratories, Pharmaceutical Industry, Biobanks, Gene Banks), Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications) – Industry Trends and Forecast to 2029.
Access Full 350 Pages PDF Report @
**Segments**
- **Material Type:** - Based on material type, the wicketed bags market can be segmented into polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET), biodegradable materials, and others. Among these, polyethylene bags are expected to dominate the market due to their cost-effectiveness and versatility in various applications.
- **Closure Type:** - The closure type segment includes options such as resealable zipper closures, heat seal closures, adhesive closures, and others. Resealable zipper closures are gaining popularity due to their convenience and ability to keep the contents fresh for longer durations.
- **End-Use Industry:** - This segment categorizes the wicketed bags market based on end-use industries like food packaging, pharmaceuticals, personal care and cosmetics, industrial, retail, and others. The food packaging industry is anticipated to hold a significant share owing to the increasing demand for convenient and sustainable packaging solutions.
**Market Players**
- **Amcor plc:** - Amcor is a key player in the wicketed bags market, offering a wide range of packaging solutions that cater to various industries. The company focuses on innovation and sustainability to meet the evolving needs of customers.
- **Bemis Company, Inc.:** - Bemis Company is another prominent player known for its advanced packaging technologies, including wicketed bags. The company's strong market presence and focus on product quality have solidified its position in the industry.
- **Berry Global, Inc.:** - Berry Global is a leading manufacturer of wicketed bags, providing customizable packaging solutions to meet specific requirements. The company's robust supply chain and global reach make it a reliable partner for customers worldwide.
- **Mondi plc:** - Mondi is a well-known name in the packaging industry, offering innovative wicketed bag solutions that prioritize sustainability and efficiency. With a strongThe wicketed bags market is witnessing significant growth and evolution driven by various segmentation factors. Material type segmentation plays a crucial role in determining the market landscape. The dominance of polyethylene (PE) bags is primarily attributed to their cost-effectiveness and versatility across different applications. Polypropylene (PP) and polyethylene terephthalate (PET) bags also offer unique advantages, but the eco-friendly trend is fueling the demand for biodegradable materials in wicketed bags. As sustainability becomes a key focus for many industries, the market is likely to witness a shift towards biodegradable options in the coming years.
Closure type segmentation further enhances the customization and functionality of wicketed bags. Resealable zipper closures have gained popularity due to their convenience and ability to maintain product freshness over extended periods. Heat seal closures and adhesive closures also play significant roles in meeting specific requirements of different industries. The choice of closure type can impact consumer convenience, product protection, and overall user experience, making it a crucial element in the wicketed bags market segmentation.
The end-use industry segment categorizes the wicketed bags market based on the applications across various sectors. The food packaging industry is poised to be a key driver of the market growth due to the rising demand for convenient and sustainable packaging solutions. With consumers placing increasing emphasis on convenience and eco-friendliness, wicketed bags offer a practical solution for food packaging companies looking to align with these preferences. Additionally, the pharmaceutical, personal care and cosmetics, industrial, retail, and other industries also contribute to the diverse applications of wicketed bags, showcasing the market's versatility and adaptability to different market demands.
Market players such as Amcor plc, Bemis Company, Inc., Berry Global, Inc., and Mondi plc are key contributors to the growth and innovation in the wicketed bags market. These companies bring a wealth of experience, technological expertise, and a strong focus on sustainability to the table, catering to the**Global Thawing Equipment Market**
- **Product:** - The thawing equipment market is segmented based on product types into manual and automatic thawing equipment. Both manual and automatic thawing equipment play a crucial role in various industries such as blood banks, hospitals, research laboratories, and the pharmaceutical industry, catering to different needs and requirements.
- **Sample:** - The sample segment categorizes the thawing equipment market based on the types of samples being thawed. This includes blood products, ovum/embryo, semen, human tissue samples, organs, stem cells, and other sample types. Each sample category requires specific thawing conditions and protocols, driving the demand for specialized thawing equipment in the market.
- **End User:** - The end-user segment of the thawing equipment market entails blood banks and transfusion centers, hospitals, research laboratories, the pharmaceutical industry, biobanks, and gene banks. Each end user has unique thawing needs based on the samples being handled, highlighting the importance of tailor-made thawing equipment solutions for different applications.
- **Application:** - The application segment further refines the market by categorizing the use of thawing equipment into therapeutic applications, research applications, clinical trials, and other applications. Thawing equipment plays a critical role in ensuring the integrity and viability of samples for various applications, making it a key component in the healthcare and research sectors.
The global thawing equipment market is witnessing significant growth and
Countries Studied:
North America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
 Objectives of the Report
To carefully analyze and forecast the size of the Thawing Equipment market by value and volume.
To estimate the market shares of major segments of the Thawing Equipment
To showcase the development of the Thawing Equipment market in different parts of the world.
To analyze and study micro-markets in terms of their contributions to the Thawing Equipment market, their prospects, and individual growth trends.
To offer precise and useful details about factors affecting the growth of the Thawing Equipment
To provide a meticulous assessment of crucial business strategies used by leading companies operating in the Thawing Equipment market, which include research and development, collaborations, agreements, partnerships, acquisitions, mergers, new developments, and product launches.
Key questions answered
How feasible is Thawing Equipment Market for long-term investment?
What are influencing factors driving the demand for Thawing Equipment near future?
What is the impact analysis of various factors in the Global Thawing Equipment market growth?
What are the recent trends in the regional market and how successful they are?
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America
Browse Trending Reports:
Forage Harvester Market Calcify Uremic Arteriolopathy Drug Market Alexipharmic Drugs Market Resectoscope Market Coal To Liquid Market Air Electrode Battery Market Power Sports Batteries Market Body Scrub Market Cataplexy Treatment Market Alveolar Capillary Dysplasia Treatment Market Quantum Computing Market Control Valves Market Hemodialysis Peritoneal Dialysis Market Breathable Films Market Utility Locator Market Food Humectants Market Electronic Safety System Market Reporter Gene Assay Market Security Assertion Markup Language Saml Authentication Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Tumblr media
0 notes
tamanna31 · 2 months ago
Text
Biopreservation Market by Regions, Type & Applications During 2023-2030
Biopreservation Market Size & Trends
The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 
Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market 
Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.
In recent years, there has been an upsurge in demand for use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. For instance, according to the Centers for Disease Control and Prevention, cardiovascular disorders and cancer are among the leading causes of disease-related mortality in adults in the U.S.  
Furthermore, the government and private sectors have shown interest and supported funding activities in research & development, leading to immense market developments. In recent years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors' focus in this field. This considerable healthcare spending is expected to fuel market growth during the forecast period.
However, the growing biopreservation market is associated with challenges such as the unavailability of skilled professionals and the lack of stringent cybersecurity measures. The high cost of labor training and software standardization are some of the contributing factors. These challenges could potentially impact overall market growth.
Biopreservation Market Segmentation
Grand View Research has segmented the global biopreservation market report on the basis of product, application, and region:
Product Outlook (Revenue, USD Billion, 2018 - 2030)
Equipment
Freezers
Refrigerators
Consumables
Vials
Straws
Microtiter Plates
Bags
Liquid Nitrogen
Media
Pre-formulated
Home-brew
Laboratory Information Management System (LIMS)
Application Outlook (Revenue, USD Billion, 2018 - 2030)
Regenerative Medicine
Cell Therapy
Gene Therapy
Others
Bio-banking
Human Eggs
Human Sperms
Veterinary IVF
Drug Discovery
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Browse through Grand View Research's Biotechnology Industry Research Reports.
The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 
The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 
Key Companies & Market Share Insights
Key players in the market are opting for strategic initiatives, funding facilities for geographical expansion, partnerships, mergers and acquisitions in key regions. For instance, in January 2023, the Hamad Medical Corporation and Qatar BioBank launched a new tissue biobank service in Qatar to provide researchers the access to high-quality tissue samples. Some of the key players in the biopreservation market include:
Azenta US, Inc.
Biomatrica, Inc.
BioLife Solutions
MVE Biological Solutions
LabVantage Solutions, Inc.
Taylor-Wharton.
Thermo Fisher Scientific, Inc.
Panasonic Corporation
X-Therma Inc.
PrincetonCryo.
Stirling Ultracold 
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
allmarketnews · 4 months ago
Text
Biobanking Market Future Aspect Analysis and Current Trends by 2024 to 2034
The Biobanking Market is crucial to the advancement of biomedical and translational research because it facilitates the collection and preservation of biological samples, including blood, tissues, and nucleic acids, which are then made available for use in studies aimed at identifying disease-relevant biomarkers. These biomarkers can then be utilized for diagnosis, prognosis, and drug response prediction. A key factor propelling the market is the increase in the quantity of research projects in this sector. These segment’s research efforts are supported by government funding available for stem cell therapies, regenerative medicine, and cell and gene therapy. Aside from this, the growing popularity of cord blood banking will support the expansion of this industry.
The Biobanking market is predicted to develop at a compound annual growth rate (CAGR) of 8.5% from 2024 to 2034, when it is projected to reach USD 184.28 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 81.50 Billion in 2024.
Know More About Biobanking Market, Download Sample Report: https://wemarketresearch.com/reports/request-free-sample-pdf/biobanking-market/1124
Biobanking refers to the organized collection and maintenance of biological specimens and their associated data. These banks store a variety of samples, such as human tissues, blood, DNA, and other biological materials, along with crucial information about the donors, including their medical history, lifestyle, and genetic data. This systematic storage allows researchers to access high-quality, well-documented specimens for their studies.
Key Market Players
The Biobanking Market is dominated by a few large companies, such as
Thermo Fisher Scientific Inc.
PHC Holdings Corporation
Becton, Dickinson and Company
QIAGEN N.V.
Merck KGaA
Sampled
Avantor, Inc.
Cryoport, Inc.
Tecan Trading AG
Azenta, Inc.
Greiner Holding AG
Others
Global Biobanking Market- Segmental Analysis
By Sample Type
Human Tissues
Stem Cells
Other Biological Samples
By Application
Therapeutics
Research
Clinical Trials
By Storage Type
Manual Storage Systems
Automated Storage Systems
By End User
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Hospitals and Diagnostic Laboratories
Purchase a Copy of this Biobanking Market research report at@ https://wemarketresearch.com/purchase/biobanking-market/1124?license=single
Challenges in Biobanking
Standardization: Developing standardized procedures for sample collection, processing, and storage is essential to ensure the quality and comparability of specimens across different biobanks.
Funding and Sustainability: Maintaining biobanks requires significant financial resources. Securing long-term funding and demonstrating the value of biobanks to stakeholders are ongoing challenges.
Technological Advances: Rapid advancements in technology, such as genomics and data analytics, require biobanks to continually update their infrastructure and capabilities.
Interoperability: Facilitating data sharing and collaboration between biobanks, both nationally and internationally, is crucial for maximizing the potential of biobanked samples.
The Future of Biobanking
The future of biobanking is bright, with several promising trends and developments:
Integration with Digital Health: The integration of biobanks with digital health technologies, such as electronic health records (EHRs) and wearable devices, can provide more comprehensive data and enhance research capabilities.
Global Collaboration: Increasing international collaboration and data sharing among biobanks will help address global health challenges and accelerate medical research.
Ethical Innovations: Continued advancements in ethical frameworks and governance models will help address the complex ethical issues associated with biobanking.
Personalized Medicine: Biobanks will play a critical role in the continued development of personalized medicine, providing the samples and data needed to tailor treatments to individual patients.
Biobanking Industry: Regional Analysis
North America Market Forecast
North America dominate the Biobanking Market with the highest revenue generating market with share of more than 47%. Leading biobanking companies, robust government support, and advances in personalized medicine foster growth. Extensive R&D activities and a high prevalence of chronic diseases also contribute to the market's expansion.
Europe Market Statistics
Europe’s biobanking market thrives due to its robust regulatory frameworks, strong healthcare systems, and substantial research funding. The region's collaborative research initiatives and cross-border projects enhance biobank operations and data sharing. Supportive policies and funding for innovative research drive the growth and efficiency of biobanks across Europe.
Conclusion
Biobanking is a cornerstone of modern medical research, offering invaluable resources for understanding diseases, developing new treatments, and improving public health. By addressing ethical, legal, and operational challenges, and embracing technological advancements, biobanks can continue to drive scientific discoveries and enhance healthcare outcomes worldwide.
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
0 notes
wellnessweb · 5 months ago
Text
Global Mesenchymal Stem Cells Market Overview
Tumblr media
The Mesenchymal Stem Cells Market size was estimated at USD 3.11 billion in 2023 and is expected to reach USD 8.22 billion by 2031 with a growing CAGR of 12.93% during the forecast period of 2024-2031.The Mesenchymal Stem Cells (MSCs) market is poised at the intersection of groundbreaking research and therapeutic innovation, heralding a new era in regenerative medicine.
With their remarkable potential to differentiate into various cell types, MSCs have captivated the biomedical field, offering promising avenues for treating a spectrum of diseases from orthopedic injuries to autoimmune disorders. As scientific understanding deepens and clinical trials expand, the market for MSC therapies anticipates exponential growth, driven by robust investment in biotechnology and increasing healthcare demand for effective, personalized treatments. This burgeoning market not only holds the key to transformative therapies but also represents a pivotal frontier in harnessing the body's own healing mechanisms for improved patient outcomes worldwide.
Get Sample Report @ https://www.snsinsider.com/sample-request/3948
Market Scope & Overview
The most recent Mesenchymal Stem Cells Market  report offers accurate data on the market's size, share, and capacity for production, demand, and growth over the coming year. According to market research, the market is changing quickly, and both the impact on the present and the future are being examined. The market research team conducted thorough primary and secondary research to gather the relevant market data.
The market size and value for each industry, channel, and other sector are discussed in the research. It also takes into account the elements and traits that could affect the expansion of the market's sales. The market's present and future states are carefully examined in the worldwide Mesenchymal Stem Cells Market  research report.
Market Segmentation Analysis
By Products and Services
Products
Cells & Cell Lines
Kits, Media, & Reagents
Others
Services
By Workflow
Cell Sourcing & Isolation
Culture & Cryopreservation
Differentiation
Characterization
By Type
Autologous
Allogeneic
By Source of Isolation
Bone Marrow
Cord Blood
Peripheral Blood
Fallopian Tube
Fetal Liver
Lung
Adipose Tissues
By Indication
Bone And Cartilage Repair
Cardiovascular Disease
Inflammatory And Immunological Diseases
Liver Diseases
Cancer
GvHD
Others
By Application
Disease Modelling
Drug Development & Discovery
Stem Cell Banking
Tissue Engineering
Toxicology Studies
Others
COVID-19 Impact Analysis
The worldwide economy is significantly impacted by the coronavirus outbreak. The most recent COVID-19 scenario analysis is included in this Mesenchymal Stem Cells Market  research report. The top businesses, distributors, and supply chain organizations in the sector are also examined in the report.
Regional Outlook
North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are the five geographic divisions of the market. The Mesenchymal Stem Cells Market report examines each regional market in great detail and sheds light on the key factors influencing it. The research takes into account factors such as market size and share, import/export ratios, supply/demand ratios, consumer demand ratios, technological advancements, R&D, infrastructure development, and a strong market presence across the board.
Competitive Analysis
To give readers a greater understanding of the important players, the study report covers cutting-edge research approaches including SWOT and Porter's Five Forces analysis. Additionally, it includes crucial data on the economy, global positioning, product portfolios, earnings, gross profit margins, and scientific and technology advancements. The key industry partnerships, product launches, and acquisitions are the subject of the Mesenchymal Stem Cells Market  research.
Key Reasons to Purchase Mesenchymal Stem Cells Market  Research Report
Market research contains critical development status, growth rates, evaluations of the competitive environment, and data on international marketing.
The research report offers a comprehensive view of the worldwide competitive climate as well as crucial details on the leading rivals and their projected future growth.
Conclusion
For industry participants and other stakeholders looking for a thorough analysis of the current market dynamics as well as realistic estimates, the Mesenchymal Stem Cells Market  research report will be a valuable resource.
About Us
SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.
When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.
Related Reports
Nasal Drug Delivery Market Growth Drivers
DNA Synthesis Market Growth Drivers
Osteoporosis Treatment Market Growth Drivers
Immunomodulators Market Growth Drivers
Proteomics Market Growth Drivers
0 notes
market-insider · 3 months ago
Text
Regenerative Medicine Market Analysis: Growth, Challenges, and Key Players
The global regenerative medicine market size is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. The presence of a strong pipeline is one of the major drivers in the regenerative medicine market. Companies invest heavily in R&D to upgrade their products with the latest technology and fulfil the unmet needs of their customers.
Tumblr media
Furthermore, with the increasing demand for disease treatment therapies, companies have focused their efforts to accelerate R&D for gene therapies that target the cause of disease at a genomic level. The cell and gene therapies in the U.S. pipeline programs (Phase I-III trials) grew from 289 in 2018 to 362 by 2019 according to the data published by PhRMA,. This represents an increase of 25% in a single year. Continuous advancements in this field would further boost the demand for regenerative medicines.
Technological advancements such as stem cells, tissue engineering, and nanotechnology has made regenerative medicines a highly interdisciplinary in field. Stem cells are undifferentiated cells, which have the capability to repair and/or regenerate into other cells such as cartilage, tendons, ligaments, muscle, and bones. In July 2021, BlueRock Therapeutics received FDA approval for its pluripotent stem cell-derived dopaminergic neuron therapy, DA01, for advanced Parkinson’s disease treatment. This approval was expected to expand the company’s offerings.
Several key players are taking strategic initiatives such as new product development, strategic alliances, and others have contributed to the regenerative medicine market growth. For instance, in November 2021, Astellas Pharma, Inc. entered into an agreement with Pantherna Therapeutics GmbH to study mRNA-based regenerative medicine. Under this initiative, Astellas' high drug discovery capabilities and Pantherna's state-of-the-art mRNA platform will be used to promote research on developing a new program. In addition, in May 2021, Bayer AG entered into a collaboration with Senti Bio for gene circuit-engineered cell therapies development for regenerative medicine.
For More Details or Sample Copy please visit link @: Regenerative Medicine Market Report
Regenerative Medicine Market Report Highlights
The therapeutics segment held the largest share in the regenerative medicine market, owing to the growing aging population coupled with an increasing rate of age-related disorders.
The rise in a number of clinical trials for stem cell and tissue-based regenerative therapies along with an increase in demand for regenerative therapies is expected to positively influence the growth of the market.
Stem cell and progenitor cell-based therapies are projected to witness significant growth owing to huge investments in the R&D space and a growing number of stem cell banks
North America dominated the market in 2023 owing to the presence of a significant number of research organizations and universities which are working on R&D of stem cell-based therapies.
Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the rapid adoption of cell-based methods in the healthcare industry.
By therapeutic category, the oncology segment dominated the segment in 2023 owing to the increasing cases of cancer globally which is rising the demand for better solutions. The growing number of robust pipelines is driving the market growth.
Gain deeper insights on the market and receive your free copy with TOC now @: Regenerative Medicine Market Report We have segmented the global Regenerative Medicine market on the basis product, therapeutic category, and region
0 notes
latestmarketresearchnews · 1 month ago
Text
Biopreservation Market Growth Drivers With Outlook And Opportunity Forecast To 2030
The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.
Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.
Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.
Product Segmentation Insights:
The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.
The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
researchreportinsight · 1 month ago
Text
Biopreservation Industry Analysis, Opportunities And Forecast Report, 2030
The global biopreservation market was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. The rapid growth of this market is driven by a variety of factors, including the extensive use of biopreservation in hospitals, research labs, and healthcare facilities. Increased funding from both government entities and private organizations in healthcare is bolstering this growth, alongside a rise in research and development activities. In addition, advancements in product development are contributing to the expanding market. For instance, BioLife Solutions introduced a high-capacity controlled freezer in April 2021, targeting the cell and gene therapy market, which enabled the company to extend its product offerings.
Despite the market's expansion, the COVID-19 pandemic posed significant challenges, such as supply chain disruptions, shortages of raw materials, and interruptions to research activities. However, the pandemic also accelerated the development of novel biologics and vaccine technologies, creating a surge in demand for biologics manufacturing and preservation. As a result, opportunities for biopreservation are expected to increase, further boosting the market.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Market
Biopreservation involves maintaining the integrity and functionality of biological materials such as stem cells, DNA, tissues, and organs by storing them at specific temperatures. This process extends their viability outside of their natural environment. Recent technological innovations, including microarrays and the incorporation of predictive models like hybrid models and API algorithms, have significantly reduced the time, cost, and complexity of biopreservation processes. These technological advancements are enhancing efficiency and performance across the industry.
Moreover, multiplex cellular imaging platforms are emerging as a transformative technology in the biopreservation field. These platforms improve the ability to monitor disease progression and offer insights into suitable diagnostic and treatment measures. They are particularly useful for specific healthcare areas like cardiology, gynecology, and point-of-care diagnostics. As these innovations progress, the role of biopreservation in modern healthcare is expected to expand.
Product Segmentation Insights:
The equipment segment dominated the biopreservation market in 2022, accounting for 78.75% of the market share. This is largely due to the growing demand for bio-banking services, which are used to preserve stem cells, DNA, plasma, and tissue cultures. The ability of biopreservation equipment to provide adequate storage capacity while requiring minimal maintenance has contributed to the widespread adoption of these solutions. As more healthcare providers and research facilities adopt biopreservation technologies, the equipment segment is expected to continue its strong performance.
The media segment, although smaller in market share, has significant growth potential. It is a crucial element of the biopreservation process, ensuring that biological materials are preserved effectively. The media segment is projected to grow at a remarkable CAGR of 29.99% from 2023 to 2030. Media applications are becoming more sophisticated, offering features that enhance research by enabling better data sharing and analysis. These advancements allow researchers to improve their capabilities in diagnosing, monitoring, and treating various health conditions, which is expected to drive significant market growth over the forecast period. As a result, the media segment will play an increasingly important role in advancing the overall effectiveness and efficiency of biopreservation.
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes
healthcaremarketanalysis · 6 months ago
Text
Biobanking Market worth $5.0 billion by 2028
Biobanking Market in terms of revenue was estimated to be worth $2.9 billion in 2023 and is poised to reach $5.0 billion by 2028, growing at a CAGR of 11.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.
Tumblr media
Browse in-depth TOC on "Biobanking Industry"
334 - Tables
48 - Figures
398 – Pages.
Download PDF Brochure:
The global biobanking market is expected to grow at a CAGR of 11.4% during the forecast period. The growth of this market is driven by increasing number of private cord blood banks has led to a rise in competition among biobanks, which has driven innovation and improvements in the quality of biobanking services. This, in turn, has fueled growth in the biobanking market as more companies seek to enter this expanding field and meet the growing demand for cord blood stem cell preservation.
The blood products segment accounted for the largest share, by sample type in the biobanking market in 2022.
Based on sample type, the global biobanking market has been segmented into blood products, human tissues, nucleic acids, human waste products, cell lines, and biological fluids. The blood products segment held the largest share of the global biobanking market in 2022. This can be attributed to the rising incidence of blood disorders and the increasing demand for various types of blood products across the globe. With the ongoing expansion of biobanks and the increasing emphasis on precision medicine, the demand for blood products in biobanking is expected to remain strong, further propelling the growth of the global biobanking market
The manual storage segment accounted for the largest share of the storage type segment in the biobanking industry in 2022.
Based on storage, the global biobanking market has been segmented into manual storage and automated storage. The manual storage segment held the larger market share in 2022. The large share of this segment can be attributed to the low cost and easy installation associated with this type of storage. Furthermore, many research centers and life science companies rely on manual processes for biological sample storage, this is further accelerating the market growth.
The North America region catered the largest share of the biobanking market in 2022.
The biobanking market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory. This can be attributed to the increasing number of biobanks and the growing investments in biobanking infrastructure. Major healthcare institutes and research organizations in North America have made substantial commitments to expanding their biobanking capabilities. Additionally, the rising prevalence of chronic diseases and the subsequent demand for personalized medicine has fueled the growth of the biobanking market in North America, with biobanks playing a pivotal role in storing and providing high-quality biological specimens for research and development purposes.
Key players in the biobanking market include Thermo Fisher Scientific, Inc. (US), PHC Holdings Corporation (Japan), Becton, Dickinson and Company (US), QIAGEN N.V. (Germany), Merck KGaA (Germany), Avantor, Inc. (US), Cryoport, Inc. (US), Tecan Trading AG (Switzerland), Azenta, Inc. (US), Greiner Holding AG (Austria), Hamilton Company (US), Micronic (Netherlands), AMSBIO (UK), Bay Biosciences LLC (US), BioKryo (Germany), SPT Labtech (UK), ASKION GmbH (Germany), Cell&Co BioServices (France), Ziath Ltd. (UK), CTIBiotech (France), Cureline (US), Firalis Group (France), Sopachem (Netherlands), ProteoGenex (US), and US Biolab Corporation, Inc. (US).
Request 10% Customization
Biobanking Market: Impact Analysis
 Drivers
Growing investments and funding for biobanks
Focus on genetic testing and precision medicine
Increasing trend in preservation of cord blood stem cells from newborns
Favorable funding scenario for research related to regenerative medicine
 Restraints
High cost of automated equipment
Issues related to biospecimen sample management
OPPORTUNITIES
Challenges
High operational cost of biobanks
Storage of samples
Recent Developments
In February 2023, PHC Corporation of North America launched the PHCbi Brand VIP ECO SMART Ultra-low Temperature Freezer with industry-leading energy efficiency.
In September 2022, Cryoport entered into a strategic partnership with BioLife Plasma Services to offer supply chain solutions and service offerings, such as bioservices and cryo-processing, for BioLife Plasma Services.
Biobanking Market Advantages:
Valuable Research Resources: Biobanks provide researchers with access to a vast collection of well-characterized biological samples and associated data. These resources serve as a valuable foundation for conducting various types of research, including genomics, proteomics, metabolomics, and epidemiological studies. Biobanks enable researchers to investigate diseases, discover new biomarkers, study genetic variations, and develop personalized therapies.
Accelerating Drug Discovery and Development: Biobanks play a crucial role in the drug discovery and development process. By providing researchers and pharmaceutical companies with access to diverse and representative samples, biobanks facilitate the identification of drug targets, testing of potential therapies, and assessment of drug efficacy and safety. This accelerates the drug development timeline, reduces costs, and enhances the success rate of clinical trials.
Facilitating Personalized Medicine: Biobanks contribute to the advancement of personalized medicine, which aims to provide tailored healthcare based on an individual's unique genetic makeup and other factors. By storing genetic information, clinical data, and biological samples, biobanks enable the identification of genetic markers associated with diseases, predicting disease risks, and guiding personalized treatment decisions. This helps healthcare providers deliver targeted therapies and improve patient outcomes.
Long-Term Sample Preservation: Biobanks employ specialized techniques and infrastructure to ensure the long-term preservation of biological samples. This enables the availability of high-quality samples over extended periods, allowing researchers to conduct longitudinal studies, analyze disease progression, and investigate long-term health outcomes. Long-term sample storage also enables retrospective studies and future research on emerging diseases or new research questions.
Collaboration and Data Sharing: Biobanks promote collaboration and data sharing among researchers, institutions, and industries. By establishing standardized protocols, ethical guidelines, and data sharing agreements, biobanks facilitate the exchange of samples, data, and knowledge. This collaboration fosters scientific discoveries, enables the replication of research findings, and maximizes the utility of stored samples.
Advancing Translational Research: Biobanks bridge the gap between basic research and clinical applications by facilitating translational research. By linking biological samples to clinical data, biobanks support the investigation of disease mechanisms, biomarker discovery, and the development of diagnostic tests. This enhances the translation of scientific knowledge into clinical practice, leading to improved disease diagnosis, prognosis, and treatment.
Overall, the biobanking market offers significant advantages by providing researchers and healthcare professionals with access to diverse, well-preserved, and well-characterized biological samples. These advantages accelerate research, drug development, and personalized medicine initiatives, ultimately contributing to advancements in healthcare and patient care.
Biobanking market - Report Highlights:
The market size is updated for the base year 2022 and forecasted from 2023 to 2028 by studying the impact of the recession on the overall biobanking industry.
The new edition includes the impact of the recession on the biobanking market (especially the region-wise impact in the geographic analysis section) in 2022. There is a variation in the growth rate of the market due to the ongoing recession.
Additional points such as ranges/scenarios, trends/disruptions impacting customers' businesses, pricing analysis, value chain analysis, supply chain analysis, ecosystem analysis, patent analysis, key conferences and events (2022-2023), list of key regulatory bodies, regulatory landscape, Porter's Five Forces analysis, key stakeholders, the influence of stakeholders on buying decisions, and buying criteria among end users have been added in the market overview chapter.
The new edition of the report provides updated financial information till 2022 (depending on availability) for each listed company in a graphical representation. This will help in the easy analysis of the present status of profiled companies in terms of their financial strength, profitability, key revenue-generating region/country, and business segment focus in terms of the highest revenue-generating segment.
Recent developments help us to understand market trends and the growth strategies adopted by players in the market.
Tracking the portfolios of prominent market players helps analyze the major products in the biobanking market. The new edition of the report provides an updated product portfolio of the companies profiled in the report.
Key market strategies/right to win, market share analysis for 2022, revenue share analysis of key market players from 2020 to 2022, and competitive leadership mapping have been added in the competitive landscape section of the report.
The new version of the report includes competitive leadership mapping for companies operating in the market. This new section is an output of a comprehensive study of the key vendors offering biobanking products. The top 25 vendors were shortlisted from a list of 50+ vendors, and these were evaluated based on market share/ranking and product footprint, rated and positioned on a 2x2 quadrant, referred to as Company Evaluation Quadrant, categorizing them as Stars, Emerging Leaders, Pervasive Players, and Participants.
The new version of the report includes the startup/SME evaluation quadrant for 10 companies operating in the biobanking market. This updated section is an output of a comprehensive study of the key startup vendors offering biobanking products. The top 10 vendors were shortlisted from a list of 50+ vendors, and these vendors were evaluated based on their product portfolio and business strategy, rated and positioned on a 2x2 quadrant, referred to as Competitive Leadership Quadrant, categorizing them as Progressive Companies, Starting Blocks, Responsive Companies, and Dynamic Companies.
In the new edition of the report, the Rest of the World is segmented into Latin America and the Middle East and Africa. Country-level markets for Brazil and the Rest of Latin America in the Latin American region have been added.
The new version of the report includes the ownership segment, which is further segmented into national/regional agencies, non-profit organizations, universities, and private organizations.
The new version of the report includes an end-user segment, which is further segmented into pharmaceutical & biotechnology companies and CROs, academic and research institutes, and hospitals.
Report Link: ( Biobanking Market )
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/biobanking-devices-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/biobanking-devices.asp
0 notes
trendingreportz · 6 months ago
Text
Tissue Banking Market - Forecast(2024 - 2030)
Tissue Banking Market Overview
The market size of Global Tissue Banking for 2019 is $42,599m and is set to grow at a CAGR of 4.0% during the forecast period 2020–2025 owing to a rise in tissue transplant cases and rising incidences of cancers, cardiovascular diseases, and diabetes. The market is witnessing several trends such as a shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, and potential cure for cancers, blood disorders, and immune and genetic diseases. With the increase in the harmonization of biobanks and research collaboration, the tissue banking market is set to grow positively during the forecast period. 
Key Takeaways
The global tissue banking market is poised to exhibit a CAGR of 4.0% percentage during the forecast period (2020–2025), attributed to rising demand for transplantation.
Major factors driving growth of the global tissue banking market is increase in the demand for regenerative medicines. 
The wide range of applications for instance storage, handling, transportation and maintenance of specimens and samples is poised to increase the market growth for the forecast period.
Request Sample
By Type - Segment Analysis
In Tissue Type segment, Blood tissue accounted for the largest share, followed by soft tissue in 2019. Blood donation has increased substantially in the past few years. In U.S., approximately 36,000 units of red blood cells are needed everyday. In Europe, approximately 1700 people opted for blood vessel tissue donation in 2013. The countries such as Spain, Italy and Sweden are the major countries with high number of donors.
By Equipment - Segment Analysis
In Equipment type, Cryopreservation Systems segment dominated the market in 2019. Cryopreservation is the process of cooling followed by storage of frozen cells to provide a continuous supply of genetically stable living cells by inhibiting all biochemical activities which are to be used for procedures such as organ donation, bone marrow transplant and others. 
Inquiry Before Buying
By Application - Segment Analysis 
In 2019, Clinical/ Therapeutic dominated the Application segment of Tissue banking market and is set to grow at a CAGR of 4.3%. Tissues preserved in tissue banks can be used for fulfilling variety of medical needs of people for example heart valves can be used in patients with heart disorders, corneal transplantation used to give visibility to blind people, tendons and ligaments used in  orthopedic surgery and blood to treat blood disorders. Clinical/therapeutic applications majorly use tissue banking for it involves different types of grafting such as cord blood, stem cell and others. 
By Geography - Segment Analysis
North America region held 35% of the global tissue banking market in 2019. This is owing to advanced technology and high awareness regarding tissue donation among the medical personnel and healthcare professionals. Europe is set to attain a significant growth owing to the increasing geriatric population and unhealthy lifestyle prevailing in the region. Asia-Pacific is poised to record rapid growth rates on the account of government initiatives for expanding medical facilities coupled with the presence of key market players in the region.
Schedule a Call
Drivers – Tissue Banking Market
Increasing Technological Advancement
Technological advancement in the healthcare sector such as development in biobanking technology coupled with a rise in regenerative tissue demand drives the market growth. The regenerative medicines cure different kinds of damaged tissues covering aging issues to injuries, which is poised to drive the demand for the Tissue Banking Market.
Challenges – Tissue Banking Market
High Cost Associated With Transplantation Procedures
The high transplant cost, bioethical issues and unavailability of tissue banks in many remote countries coupled with stringent government rules and regulations regarding testing and clearance documents negatively impact the growth of the global tissue banking market over the forecast period. 
Buy Now
The Major Players in this Market Include
The leading players in the tissue banking market are AMS Biotechnology (Europe) Limited, Avantor, Inc (VWR International), BioCision LLC, Brooks Automation, Custom Biogenic Systems, Eppendorf AG, Hamilton Company, Merck KGaA and Thermo Fisher Scientific, Inc.
Acquisitions/Product Launches:
In 2017, Natera, a leader in genetic testing, launched Evercord, a new offering that enables expectant parents to collect, store, and potentially retrieve their newborn’s cord, blood, and tissue for therapeutic use in transplantation and regenerative medicine applications.
In 2013, three institutes at the National Institute of Health, including the National Institute of Mental Health (NIMH), the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Child Health and Human Development (NICHD) launched a joint initiative called as ‘NeuroBioBank’ in the U.S. It links together six large organ and tissue repositories through a common web portal.
In October 2018, MTF Biologics announced the formation of a new tissue recovery relationship with Regenerative Biologics, Inc. The organizations seek to provide expanded birth-tissue donation opportunities for expectant mothers and their families and enhance patients’ access to high-quality placental tissues for wound care applications.
0 notes
industrynewsupdates · 2 months ago
Text
Biopreservation Market Key Companies, Growth and Forecast Report, 2030
The global biopreservation market size was valued at USD 2.18 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 28.30% from 2023 to 2030. 
Biopreservation is experiencing growth due to various factors such as extensive usage in hospitals and labs, rising funding assistance from government and private partners in healthcare, an upsurge in research & development, and growing advancement in terms of product development. For example, in April 2021, BioLife Solutions launched a new high-capacity controlled freezer to cater to the cell and gene therapy market, which helped the company expand its existing product portfolio. The market experienced a major hindrance during the COVID-19 pandemic with supply chain issues, unavailability of raw materials, and hindrances in research activities among other reasons. However, the pandemic also accelerated the growth of novel biologics, and vaccine technologies. Due to these factors, opportunities for biologics manufacturing and preservation are anticipated to increase, thus generating further demand for biopreservation.
Biopreservation is a process that helps maintain the integrity and functionality of biological products such as stem cells, DNA, tissues, and organs under different temperatures, thereby prolonging their lifespan outside their natural environment. Technology innovations include microarrays or incorporation of a wide range of predictive models, such as hybrid models, and various API algorithms which help reduce the time, cost and complexity of the overall process. Furthermore, the advent of multiplex cellular imaging platforms is anticipated to enhance the biopreservation ability to help understand disease progression and suggest suitable diagnostic & treatment measures to follow, specifically for cardiology, gynecology, and point-of-care applications.
Gather more insights about the market drivers, restrains and growth of the Biopreservation Marke
Biopreservation Market Report Highlights
• By product, the equipment segment held the largest revenue share of over 78.75% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. Increasing demand for modified genetic material in the global market is also fueling the growth
• The bio-banking application segment held the largest revenue share in 2022. This can be attributed to rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals
• North America dominated the global market in 2022 due to the advancement in biomedical research, the development of advanced therapies, and the upsurge in research activities related to DNA sequencing and bioinformatics
• Asia Pacific is expected to grow considerably in the future owing to rising investments in Asian countries and increasing partnerships and collaborations with key players
Browse through Grand View Research's Biotechnology Industry Research Reports.
• The global cancer stem cells market size was valued at USD 2.89 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2030.
• The global DNA methylation market size was valued at USD 1.47 billion in 2023. It is expected to expand at a compound annual growth rate (CAGR) of 14.1% from 2024 to 2030.
Biopreservation Market Segmentation
Grand View Research has segmented the global biopreservation market on the basis of product, application, and region:
Biopreservation Product Outlook (Revenue, USD Billion, 2018 - 2030)
• Equipment
o Freezers
o Refrigerators
o Consumables
o Vials
o Straws
o Microtiter Plates
o Bags
o Liquid Nitrogen
• Media
o Pre-formulated
o Home-brew
• Laboratory Information Management System (LIMS)
Biopreservation Application Outlook (Revenue, USD Billion, 2018 - 2030)
• Regenerative Medicine
o Cell Therapy
o Gene Therapy
o Others
• Bio-banking
o Human Eggs
o Human Sperms
o Veterinary IVF
• Drug Discovery
Biopreservation Regional Outlook (Revenue, USD Billion, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o Germany
o U.K.
o France
o Italy
o Spain
o Denmark
o Sweden
o Norway
• Asia Pacific
o China
o Japan
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa (MEA)
o South Africa
o Saudi Arabia
o UAE
o Kuwait
Order a free sample PDF of the Biopreservation Market Intelligence Study, published by Grand View Research.
0 notes